Impact of Oral Fast Release Amantadine on Movement Performance in Patients with Parkinson’s Disease

Author： Muhlack Siegfried Müsch Patricia Konietzka Sandra Woitalla Dirk Przuntek Horst Müller Thomas

Publisher： MDPI

E-ISSN： 1999-4923|2|3|313-320

ISSN： 1999-4923

Source： Pharmaceutics, Vol.2, Iss.3, 2010-09, pp. : 313-320

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Protein Kinases and Parkinson’s Disease

By Mehdi Syed Jafar Rosas-Hernandez Hector Cuevas Elvis Lantz Susan M. Barger Steven W. Sarkar Sumit Paule Merle G. Ali Syed F. Imam Syed Z.

International Journal of Molecular Sciences, Vol. 17, Iss. 9, 2016-09 ,pp. : 1585-1585

MDPI

Access to resources Recommend Favorite

Mitochondria: A Therapeutic Target for Parkinson’s Disease?

By Luo Yu Hoffer Alan Hoffer Barry Qi Xin

International Journal of Molecular Sciences, Vol. 16, Iss. 9, 2015-09 ,pp. : 20704-20730

MDPI

Access to resources Recommend Favorite

Roles of PTEN with DNA Repair in Parkinson’s Disease

By Ogino Mako Ichimura Mayuko Nakano Noriko Minami Akari Kitagishi Yasuko Matsuda Satoru

International Journal of Molecular Sciences, Vol. 17, Iss. 6, 2016-06 ,pp. : 954-954

MDPI

Access to resources Recommend Favorite

Parkinson’s Disease: From Pathogenesis to Pharmacogenomics

By Cacabelos Ramón

International Journal of Molecular Sciences, Vol. 18, Iss. 3, 2017-03 ,pp. : 551-551

MDPI

Access to resources Recommend Favorite

Neuroprotective Properties of Mildronate, a Small Molecule, in a Rat Model of Parkinson’s Disease

By Klusa Vija Z. Isajevs Sergejs Svirina Darja Pupure Jolanta Beitnere Ulrika Rumaks Juris Svirskis Simons Jansone Baiba Dzirkale Zane Muceniece Ruta Kalvinsh Ivars Vinters Harry V.

International Journal of Molecular Sciences, Vol. 11, Iss. 11, 2010-11 ,pp. : 4465-4487

MDPI

Access to resources Recommend Favorite